Commentary
RANKL inhibitors for osteosarcoma treatment: hope and caution
Abstract
Chen and collaborators propose RANKL blockade for the treatment and prevention of aggressive RANKL-overexpressing osteosarcoma (OS) in humans. Here we comment the main findings, putative applications and concerns.
